Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; and.
Department of Psychiatry, Kuopio University Hospital, Kuopio, Finland.
Am J Clin Nutr. 2016 May;103(5):1337-43. doi: 10.3945/ajcn.115.128629. Epub 2016 Mar 23.
The role of n-6 (ω-6) polyunsaturated fatty acids (PUFAs) in type 2 diabetes (T2D) is inconclusive. In addition, little is known about how factors involved in PUFA metabolism, such as zinc, may affect the associations.
We investigated the associations of serum n-6 PUFAs and activities of enzymes involved in PUFA metabolism, Δ5 desaturase (D5D) and Δ6 desaturase (D6D), with T2D risk to determine whether serum zinc concentrations could modify these associations.
The study included 2189 men from the prospective Kuopio Ischaemic Heart Disease Risk Factor Study, aged 42-60 y and free of T2D at baseline in 1984-1989. T2D was assessed by self-administered questionnaires, by fasting and 2-h oral-glucose-tolerance test blood glucose measurement at re-examination rounds 4, 11, and 20 y after baseline, and by record linkage to the hospital discharge registry and the reimbursement register on diabetes medication expenses. Multivariate-adjusted Cox proportional hazards regression models were used to analyze associations.
During the average follow-up of 19.3 y, 417 men developed T2D. Those with higher estimated D5D activity (extreme-quartile HR: 0.55; 95% CI: 0.41, 0.74; P-trend < 0.001) and higher concentrations of total n-6 PUFAs (HR: 0.54; 95% CI: 0.41, 0.73; P-trend < 0.001), linoleic acid (LA; HR: 0.52; 95% CI: 0.39, 0.70; P-trend < 0.001), and arachidonic acid (AA; HR: 0.62; 95% CI: 0.46, 0.85; P-trend = 0.007) had a lower risk and those with higher concentrations of γ-linolenic acid (GLA; HR: 1.28; 95% CI: 0.98, 1.68; P = 0.021) and dihomo-γ-linolenic acid (DGLA; HR: 1.38; 95% CI: 1.04, 1.84; P-trend = 0.005) and higher D6D activity had a higher (HR: 1.50; 95% CI: 1.14, 1.97; P-trend < 0.001) multivariate-adjusted risk of T2D. Zinc mainly modified the association with GLA on T2D risk, with a higher risk observed among those with serum zinc concentrations above the median (P-interaction = 0.04).
Higher serum total n-6 PUFA, LA, and AA concentrations and estimated D5D activity were associated with a lower risk of incident T2D, and higher GLA and DGLA concentrations and estimated D6D activity were associated with a higher risk. In addition, a higher serum zinc concentration modified the association of GLA on the risk of T2D.
n-6(ω-6)多不饱和脂肪酸(PUFA)在 2 型糖尿病(T2D)中的作用尚无定论。此外,人们对参与 PUFA 代谢的因素(如锌)如何影响这些关联知之甚少。
我们研究了血清 n-6 PUFAs 和参与 PUFA 代谢的酶(Δ5 去饱和酶(D5D)和 Δ6 去饱和酶(D6D))的活性与 T2D 风险的关联,以确定血清锌浓度是否可以改变这些关联。
这项研究包括 2189 名来自前瞻性库奥皮奥缺血性心脏病风险因素研究的男性,年龄在 42-60 岁之间,在 1984-1989 年基线时无 T2D。T2D 通过自我管理问卷、空腹和 2 小时口服葡萄糖耐量试验血糖测量在基线后 4、11 和 20 年的复查轮次中进行评估,并通过与医院出院登记处和糖尿病药物费用报销登记处的记录链接进行评估。使用多变量调整的 Cox 比例风险回归模型分析关联。
在平均 19.3 年的随访期间,417 名男性患上了 T2D。那些具有更高估计的 D5D 活性(极端四分位 HR:0.55;95%CI:0.41,0.74;P-趋势<0.001)和更高浓度的总 n-6 PUFAs(HR:0.54;95%CI:0.41,0.73;P-趋势<0.001)、亚油酸(LA;HR:0.52;95%CI:0.39,0.70;P-趋势<0.001)和花生四烯酸(AA;HR:0.62;95%CI:0.46,0.85;P-趋势=0.007)的风险较低,而那些具有更高浓度的 γ-亚麻酸(GLA;HR:1.28;95%CI:0.98,1.68;P=0.021)和二高-γ-亚麻酸(DGLA;HR:1.38;95%CI:1.04,1.84;P-趋势=0.005)和更高的 D6D 活性具有更高的(HR:1.50;95%CI:1.14,1.97;P-趋势<0.001)调整后的 T2D 风险。锌主要改变了与 GLA 对 T2D 风险的关联,在血清锌浓度高于中位数的人群中观察到更高的风险(P 交互=0.04)。
血清总 n-6 PUFA、LA 和 AA 浓度和估计的 D5D 活性较高与 T2D 发生风险降低相关,而 GLA 和 DGLA 浓度和估计的 D6D 活性较高与风险增加相关。此外,较高的血清锌浓度改变了 GLA 对 T2D 风险的关联。